Patent details
EP1556027 Title: MODIFIED AMINO ACID 5-CNAC FOR THE INHIBITION OF PLATELET AGGREGATION
Basic Information
- Publication number:
- EP1556027
- PCT Application Number:
- PCT/EP/2003/007739
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP037638780
- PCT Publication Number:
- WO/2004/006907
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- MODIFIED AMINO ACID 5-CNAC FOR THE INHIBITION OF PLATELET AGGREGATION
- French Title of Invention:
- AMINOACIDE MODIFIE 5-CNAC POUR INHIBER L'AGREGATION PLAQUETTAIRE
- German Title of Invention:
- MODIFIZIERTE AMINOSAEURE 5-CNAC ZUR HEMMUNG DER THROMBOZYTENAGGREGATION
- SPC Number:
Dates
- Filing date:
- 16/07/2003
- Grant date:
- 28/12/2011
- EP Publication Date:
- 28/12/2011
- PCT Publication Date:
- 22/01/2004
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 27/07/2005
- EP B1 Publication Date:
- 28/12/2011
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 16/07/2012
- Expiration date:
- 16/07/2023
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 16/07/2003
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
- Name:
- Novartis Pharma GmbH
- Address:
- Brunner Strasse 59, 1230 Wien, Austria (AT)
Inventor
1
- Name:
- AZRIA Moise
- Address:
- Switzerland (CH)
2
- Name:
- BATEMAN Simon, David
- Address:
- United States (US)
Priority
- Priority Number:
- 396898 P
- Priority Date:
- 17/07/2002
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/166;
| Filing date | Document type | Number of pages |
|---|